|
1
|
Raghu G, Collard HR, Egan JJ, Martinez FJ,
Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, et
al: An official ATS/ERS/JRS/ALAT statement: Idiopathic pulmonary
fibrosis: Evidence-based guidelines for diagnosis and management.
Am J Respir Crit Care Med. 183:788–824. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
King TE Jr, Albera C, Bradford WZ,
Costabel U, Hormel P, Lancaster L, Noble PW, Sahn SA, Szwarcberg J,
Thomeer M, et al: Effect of interferon gamma-1b on survival in
patients with idiopathic pulmonary fibrosis (INSPIRE): A
multicentre, randomized, placebo-controlled trial. Lancet.
374:222–228. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Raghu G, Rochwerg B, Zhang Y, Garcia CA,
Azuma A, Behr J, Brozek JL, Collard HR, Cunningham W, Homma S, et
al: An official ATS/ERS/JRS/ALAT clinical practice guideline:
Treatment of idiopathic pulmonary fibrosis An update of the 2011
clinical practice guideline. Am J Respir Crit Care Med. 192:e3–e19.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Merrill WW and Reynoldss HY: Bronchial
lavage in inflammatory lung disease. Clin Chest Med. 4:71–84.
1983.PubMed/NCBI
|
|
5
|
Katzenstein AL and Myers JL: Idopathic
pulmonary fibrosis: Clinical relevance of pathologic
classification. Am J Respir Crit Care Med. 157:1301–1315. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Munger JS, Huang X, Kawakatsu H, Griffiths
MJ, Dalton SL, Wu J, Pittet JF, Kaminski N, Garat C, Matthay MA, et
al: The integrin alpha v beta 6 binds and activates latent TGF beta
1: A mechanism for regulating pulmonary inflammation and fibrosis.
Cell. 96:319–328. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Remy-Jardin M, Giraud F, Remy J, Copin MC,
Gosselin B and Duhamel A: Importance of groundglass attenuation in
chronic diffuse infiltrative lung disease: Pathologic-CT
correlation. Radiology. 189:693–698. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Baroke E, Gauldie J and Kolb M: New
treatment and markers of prognosis for idiopathic pulmonary
fibrosis: Lessons learned from translational research. Expert Rev
Respir Med. 7:465–478. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Selman M, King TE and Pardo A: American
Thoracic Society; European Respiratory Society and American College
of Chest Physicians: Idiopathic pulmonary fibrosis: Prevailing and
evolving hypotheses about its pathogenesis and implications for
therapy. Ann Intern Med. 134:136–151. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Noble PW, Barkauskas CE and Jiang D:
Pulmonary fibrosis: Patterns and perpetrators. J Clin Invest.
122:2756–2762. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lawson WE, Cheng DS, Degryse AL, Tanjore
H, Polosukhin VV, Xu XC, Newcomb DC, Jones BR, Roldan J, Lane KB,
et al: Endoplasmic reticulum stress enhances fibrotic remodeling in
the lungs. Pro Natl Acad Sci USA. 108:10562–10567. 2011. View Article : Google Scholar
|
|
12
|
Lawson WE, Crossno PF, Polosukhin VV,
Roldan J, Cheng DS, Lane KB, Blackwell TR, Xu C, Markin C, Ware LB,
et al: Endoplasmic reticulum stress in alveolar epithelial cells is
prominent in IPF: Association with altered surfactant protein
processing and herpesvirus infection. Am J Physiol Lung Cell Mol
Physiol. 294:L1119–L1126. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen CY, Peng WH, Wu LC, Wu CC and Hsu SL:
Luteolin ameliorates experimental lung fibrosis both in vivo and in
vitro: Implications for therapy of lung fibrosis. J Agric Food
Chem. 58:11653–11661. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Broekelmann TJ, Limper AH, Colby TV and
McDonald JA: Transforming growth factor beta-1 is present at sites
of extracellular matrix gene expression in human pulmonary
fibrosis. Proc Natl Acad Sci USA. 88:6642–6646. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ho YY, Lagares D, Tager AM and Kapoor M:
Fibrosis-a lethal component of systemic sclerosis. Nat Rev
Rheumatol. 10:390–402. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Park S and Lee EJ: Recent advances in
idiopathic pulmonary fibrosis. Tuber Respir Dis (Seoul). 74:1–6.
2013. View Article : Google Scholar
|
|
17
|
Chen J, He B and Liu X: Experimental study
on effect of folium Ginkgo biloba in treating pulmonary
interstitial fibrosis in rats. Zhongguo Zhong Xi Yi Jie He Za Zhi.
20:441–443. 2000.(In Chinese). PubMed/NCBI
|
|
18
|
Xiao-Jiao LI, Guo G, Cheng ZX, Hui-Yun LI,
Zhang HS and Zhong QC: Effect of Shenmai Kaifei San on the level of
IL-6, TNF-α and TGF-β1 in patients with systemic sclerosis
complicated by pulmonary fibrosis. Rheumatism and Arthritis.
5:10–12. 2016.(In Chinese).
|
|
19
|
Ma X, Chen R, Liu X, Xie J, Si K and Duan
L: Effects of matrine on JAK-STAT signaling transduction pathways
in bleomycin-induced pulmonary fibrosis. Afr J Tradit Complement
Altern Med. 10:442–448. 2013.PubMed/NCBI
|
|
20
|
He WW, Zhang DP and Xie N: Effect of
curcumin on proliferation, apoptosis and the extracellular matrix
of human embryonic lung fibroblast. Pharm Clin Res. 21:322–325.
2013.
|
|
21
|
Thannickal VJ and Horowitz JC: Evolving
concepts of apoptosis in idiopathic pulmonary fibrosis. Proc Am
Thorc Soc. 3:350–356. 2006. View Article : Google Scholar
|
|
22
|
Nkyimbeng T, Ruppert C, Shiomi T, Dahal B,
Lang G, Seeger W, Okada Y, D'Armiento J and Günther A: Pivotal role
of matrix metalloproteinase 13 in extracellular matrix turnover in
idiopathic pulmonary fibrosis. PLoS One. 8:e732792013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tsukui T, Ueha S, Abe J, Hashimoto S,
Shichino S, Shimaoka T, Shand FH, Arakawa Y, Oshima K, Hattori M,
et al: Qualitative rather than quantitative changes are hallmarks
of fibroblasts in bleomycin-induced pulmonary fibrosis. Am J
Pathol. 183:758–773. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kliment CR and Oury TD: Oxidative stress,
extracellular matrix targets, and idiopathic pulmonary fibrosis.
Free Radic Biol Med. 49:707–717. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Meltzer EB and Noble PW: Idiopathic
pulmonary fibrosis. Orphanet J Rare Dis. 3:82008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hinz B, Phan SH, Thannickal VJ, Galli A,
Bochaton-Piallat ML and Gabbiani G: The myofibroblast: One
function, multiple origins. Am J Pathol. 170:1807–1816. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zheng L, Zhou Z, Lin L, Alber S, Watkins
S, Kaminski N, Choi AM and Morse D: Carbon monoxide modulates
alpha-smooth muscle actin and small proline rich-1a expression in
fibrosis. Am J Respir Cell Mol Biol. 41:85–92. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Daniil ZD, Papageorgiou E, Koutsokera A,
Kostikas K, Kiropoulos T, Papaioannou AI and Gourgoulianis KI:
Serum levels of oxidative stress as a marker of disease severity in
idiopathic pulmonary fibrosis. Pulm Pharmacol Ther. 21:26–31. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bowler RP and Crapo JD: Oxidative stress
in airways: Is there a role for extracellular superoxide dismutase.
Am J Respir Crit Care Med. 166:S38–S43. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Serra V, von Zglinicki T, Lorenz M and
Saretzki G: Extracellular superoxide dismutase is a major
antioxidant in human fibroblasts and slows telomere shortening. J
BiolChem. 278:6824–6830. 2003.
|
|
31
|
Chen X and Chen WZ: Recent phremacological
progress of Ginkgobiloba extract for cardiovascular and
neuronal disease. Chin J Integ Trad West Med. 2:3001996.(In
Chinese).
|
|
32
|
Isah T: Rethinking Ginkgo biloba L:
Medicinal uses and conservation. Pharmacogn Rev. 9:140–148. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang CG, Dai Y, Li DL and Ma KY: Ginkgo
biloba leaf extract action in scavenging free radicals and
reducing mutagenicity and toxicity of cigarette smoke in vivo. J
Environ Sci Health A Tox Hazard Subst Environ Eng. 45:498–505.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Akiba S, Chiba M, Mukaida Y, Tamura A and
Sato T: The leaf extract of Ginkgo Biloba L. suppresses
oxidized LDL-stimulated fibronectin production through an
antioxidant action in rat mesangial cells. Br J Pharmacol.
142:419–424. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Su X, Ma Y, Huang R, Wang X and Wang Y:
Effects of shenmai injection on blood SOD activity and MDA level in
senile patients with coronary heart disease. J Tradit Chin Med.
25:50–53. 2005.PubMed/NCBI
|
|
36
|
Zhao LM, Ma LJ, Zhang LX and Wu JZ:
Shenmai injection inhibiting the extracellular signal regulated
kinase-lnduced human airway smooth muscle proliferation in asthma.
Chin J Integr Med. 16:331–336. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yu YH, Cui NQ, Fu Q and Li J: Change of
TH1/TH2 cytokine equilibrium in rats with severe sepsis and
therapeutic effect of recombinant interleukin-12 and shenmai
injection. Chin J Integr Med. 11:136–141. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li Y, Wang B, Zhou C and Bi Y: Matrine
induces apoptosis in angiotensin II-stimulated hyperplasia of
cardiac fibroblasts: Effects on Bcl-2/Bax expression and caspase-3
activation. Basic Clin Pharmacol Toxicol. 101:1–8. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Jung E, Lee J, Huh S, Lee J, Hwang H, Kim
Y, Kim YW, Byun SY and Park D: Matrine inhibits PMA-induced MMP-1
expression in human dermal fibroblasts. Biofactors. 33:121–128.
2008. View Article : Google Scholar : PubMed/NCBI
|
